title: Reply: comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'.
authors.affiliation: Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
authors.forename: J
authors.initials: J
authors.lastname: Szkandera
authors.forename: M
authors.initials: M
authors.lastname: Pichler
authors.forename: M
authors.initials: M
authors.lastname: Stotz
authors.forename: A
authors.initials: A
authors.lastname: Gerger
mesh_terms: D003110:Colonic Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D009504:Neutrophils / Q000473:pathology*